Featured Publications
Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder
Schnakenberg Martin AM, Bartolomeo L, Howell J, Hetrick WP, Bolbecker AR, Breier A, Kidd G, O’Donnell B. Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder. European Archives Of Psychiatry And Clinical Neuroscience 2017, 268: 653-661. PMID: 28936548, PMCID: PMC7126185, DOI: 10.1007/s00406-017-0839-1.Peer-Reviewed Original ResearchMeSH KeywordsAdultAuditory PerceptionFemaleHallucinationsHumansMaleMiddle AgedSchizophreniaYoung AdultConceptsAuditory verbal hallucinationsSchizophrenia spectrum disordersAuditory perceptionSZ individualsFeature perceptionVerbal hallucinationsSpectrum disorderAuditory featuresImpaired auditory perceptionSchizophrenia Voices QuestionnaireBasic Auditory CapabilitiesTemporal order discriminationAuditory hallucinatory experiencesCognitive processingTone taskOrder discriminationHamilton ProgramHallucinatory experiencesGreater deficitsSZ groupAuditory hallucinationsAuditory capabilitiesPerceptionVoice QuestionnaireIntellectual impairment
2018
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
Boggs DL, Surti T, Gupta A, Gupta S, Niciu M, Pittman B, Schnakenberg Martin AM, Thurnauer H, Davies A, D’Souza D, Ranganathan M. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. Psychopharmacology 2018, 235: 1923-1932. PMID: 29619533, DOI: 10.1007/s00213-018-4885-9.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAdultAffectAntipsychotic AgentsCannabidiolChronic DiseaseCognitionCognitive DysfunctionDouble-Blind MethodFemaleFollow-Up StudiesHumansMaleMental Status and Dementia TestsMiddle AgedOutpatientsPsychiatric Status Rating ScalesSchizophreniaSchizophrenic PsychologyTreatment OutcomeConceptsMATRICS Consensus Cognitive BatterySide effectsChronic schizophreniaAntipsychotic-treated patientsMovement side effectsFixed-dose studyPlacebo-treated subjectsWeeks of treatmentPANSS total scoreEffects of cannabidiolWorsening of moodNegative Syndrome ScaleAntipsychotic-treated outpatients× time effect× time interactionMCCB composite scoreOral cannabidiolCBD groupClinical trialsParallel groupPANSS scoresMethodsThis studyPsychotic symptomsConsensus Cognitive BatterySyndrome Scale